Quick genetic test for unborn babies hits a snag: study withdrawn
NCT ID NCT05834621
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study aimed to see if a rapid whole genome sequencing test on amniotic fluid could give faster genetic diagnoses for fetuses with suspected genetic diseases. Researchers planned to compare results from amniotic fluid and blood samples from up to 90 families. However, the study was withdrawn before enrolling any participants, so no results are available.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMNIOCENTESIS AFFECTING FETUS OR NEWBORN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A helping hand for black families facing early psychosis
- Can a peer-led program heal trauma in families touched by borderline personality disorder?
- Could a Nurse-Led support program ease Families' trauma after ICU?
- Hope for caregivers: logotherapy boosts meaning in life for families of schizophrenia patients
- ER visit sparks life planning: study tests motivational interviewing for advance care planning
- Flashing lights and tones could stop Alzheimer's before it starts